Moderna Seeks FDA Approval For COVID-19 Booster Shot
Moderna Inc (NASDAQ: MRNA) is pushing ahead for authorization of a third shot of its COVID-19 vaccine as a booster.
Moderna Reports Submission Of Initial Data To FDA For Its COVID-19 Vaccine Booster
mRNA-1273 at 50 µg dose level induced robust antibody responses of more than 40x against the Delta variant (B.1.617.2)
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc. (NASDAQ:MRNA), a biotechnology company
Moderna And DexCom Lead The Nasdaq-100
U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide.
Belgian Study Shows Moderna Covid Vaccine Creates Twice as Many Antibodies as Pfizer
-Bloomberg
https://www.bloomberg.com/news/articles/2021-08-31/moderna-jab-spurs-double-pfizer-covid-antibody-levels-in-study
Why Moderna Shares Dropped Lower Today
Moderna Inc (NASDAQ: MRNA) shares closed almost 3% lower in the regular session on Monday.